Trial Profile
Long term outcomes of adefovir dipivoxil plus lamivudine in the treatment of chronic hepatitis B with or without multidrug resistance mutations.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 Dec 2015 New trial record